A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS-Reference-Cited by-同舟云学术

A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS

Published:2008-10 Issue:10 Volume:35 Page:899-910
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:

Author:

Mao Xin,Orchard Guy,Mitchell Tracey J.,Oyama Noritaka,Russell-Jones Robin,Vermeer Maarten H.,Willemze Rein,van Doorn Remko,Tensen Cornelis P.,Young Bryan D.,Whittaker Sean J.

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0560.2007.00924.x/fullpdf

Reference54 articles.

1. Close encounters of many kinds: fos-Jun interactions that mediate transcription regulatory specificity;Chinenov;Oncogene,2001

2. Fortuitous convergences: the beginnings of JUN;Vogt;Nature Rev Cancer,2002

3. AP-1: a double-edged sword in tumorigenesis;Eferl;Nat Rev Cancer,2003

4. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun;Chiu;Cell,1989

5. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers;Deng;Genes Dev,1993

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression;Blood Advances;2024-06-13

2. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides;Healthcare;2023-02-18

3. Cutaneous T-Cell Lymphoma and Other Lymphoproliferative Dermatological Diseases;Dermatology in Public Health Environments;2023

4. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma;International Journal of Molecular Sciences;2021-07-23

5. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy;Cancers;2021-04-16